drugset / Trial / NCT06502262

A Comparative Study of Intrathecal Dexmedetomidine and Fentanyl As Additives to Bupivacaine in Pott's Fracture

NCT06502262

Phase 1 Completed 60 enrolled Ain Shams University
RandomizedParallel-groupTriple-blindPrevention

Summary

The aim of this study is to compare the addition of intrathecal dexmedetomidine or fentanyl as adjuvants to hyperbaric bupivacaine in the onset and duration of sensory and motor block, and postoperative analgesia.

Timeline

Start
2024-01-15
Primary completion
2024-08-15
Completion
2024-09-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bupivacaine Other / unclassified 15 mg Intrathecal
Comparator Dexmedetomidine Other / unclassified 5 ug Intrathecal
Comparator Fentanyl Other / unclassified 25 ug Intrathecal

Indications

No indication recorded.